References
- Ezzati M, Lopez A D, Rodgers A, Murray C JL. Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors. World Health Organization, Geneva 2004
- Rehm J, Room R. The global burden of disease attributable to alcohol, tobacco and illicit drugs. Preventing harmful substance use: the evidence base for policy and practice, T Stockwell, P Gruenewald, J Toumbourou, W Loxley. Wiley, Chichester 2005; 25–41
- Baliunas D, Patra J, Rehm J, et al, Smoking-attributable mortality and potential years of life lost in Canada 2002: conclusions for prevention and policy. Chronic Diseases in Canada, in press
- Rehm J, Patra J, Popova S. Alcohol-attributable mortality and potential years of life lost in Canada 2001: implications for prevention and policy. Addiction 2006; 101: 373–384
- Popova S, Rehm J, Patra J. Illegal drug-attributable mortality and potential years of life lost in Canada 2002: conclusions for prevention and policy. Contemporary Drug Problems, in press
- Single E, Robson L, Xie X, Rehm J. The economic costs of alcohol, tobacco and illicit drugs in Canada 1992. Addiction 1998; 7: 991–1006
- Andlin-Sobocki P. Economic evidence in addiction: a review. Eur J Health Econ 2004; 5(Suppl. 1)S5–S12
- Andlin-Sobocki P, Rehm J. Cost of addiction in Europe. Eur J Neurol 2005; 12(suppl. 1)28–33
- Rehm J, Room R, Graham K, Monteiro M, Gmel G, Sempos C T. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease—an overview. Addiction 2003; 98: 1209–1228
- Rehm J, Sempos C T, Trevisan M. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease—a review. J Cardiovasc Risk 2003; 10: 15–20
- Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction 2000; 95: 1505–1523
- Mathers C D, Stein C, Ma Fat D, et al. Global Burden of Disease 2000 (version 2): methods and results. Global Program on Evidence for Health Policy, World Health Organization, Geneva 2002, GPE discussion paper no. 50
- Ezzati M, Lopez A D, Rodgers A, Vander Horn S, Murray C JL, the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347–1360
- Ezzati M, Vander Horn S, Rodgers A, Lopez A D, Mathers C D, Murray C JL, the Comparative Risk Assessment Collaborating Group. Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 2003; 362: 271–280
- Rehm J, Rehn N, Room R, et al. The global distribution of average volume of alcohol consumption and patterns of drinking. Eur Addict Res 2003; 9: 147–156
- Warner-Smith M, Lynskey M, Hall W, Monteiro M. Challenges and first solutions of estimating mortality attributable to illicit drug use. Eur Addict Res 2001; 7: 104–116
- Peto R, Lopez A D, Boreham J, Thun M, Heath C, Jr. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 339: 1268–1278
- Ezzati M, Lopez A D. Estimates of global mortality attributable to smoking in 2000. Lancet 2003; 362: 847–852
- Ezzati M, Kammen D M. The health impacts of exposure to indoor air pollution from solid fuels in developing countries: knowledge, gaps, and data needs. Environ Health Perspect 2002; 110: 1057–1068
- Walter S D. The estimation and interpretation of attributable risk in health research. Biometrics 1976; 32: 829–849
- Walter S D. Prevention of multifactorial disease. Am J Epidemiol 1980; 112: 409–416
- Gutjahr E, Gmel G, Rehm J. Relation between average alcohol consumption and disease: an overview. Eur Addict Res 2001; 7: 117–127
- Rehm J, Room R, Monteiro M, . Alcohol use. Comparative quantification of health risks. Global and regional burden of disease attributable to selected major risk factors, vol. 1, M Ezzati, A D Lopez, A Rodgers, C JL Murray, et al. World Health Organization, Geneva 2004; 959–1108
- Garfinkel L. Selection, follow-up and analysis in the American Cancer Society prospective studies. Selection, follow-up and analysis in prospective studies: a workshop, L Garfinkel, O Ochs, M Mushinkski. National Cancer Institute. NCI Monograph no. 67, Bethesda, MD 1985
- Liu B Q, Peto R, Chen Z M, et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ 1998; 317: 1411–1422
- Degenhardt L, Hall W D, Warner-Smith M, Lynskey M. Illicit drug use. Comparative risk assessment, vol. I, M Ezzati, A Lopez, C Murray. World Health Organization, Geneva 2004; 1109–1176
- World Health Organisation. World health report 2002: reducing risks, promoting healthy life. World Health Organisation, Geneva 2002
- Murray C JL, Salomon J A, Mathers C. A critical examination of summary measures of population health. Bull World Health Org 2000; 8: 981–994
- The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020, C JL Murray, A D Lopez. Harvard School of Public Health on behalf of the World Health Organisation and the World Bank, Boston 1996
- World Health Organisation. World health report 2000: health systems: improving performance. World Health Organisation, Geneva 2000
- McKee M, Britton A. The positive relationship between alcohol and heart disease in eastern Europe: potential physiological mechanisms. J Roy Soc Med 1998; 91: 402–407
- Puddey I B, Rakic V, Dimmitt S B, Beilin L J. Influence of drinking on cardiovascular disease and cardiovascular risk factors—a review. Addiction 1999; 94: 649–663
- Gmel G, Rehm J. Measuring alcohol consumption. Contemp Drug Probl 2004; 31: 467–540
- Midanik L T. Validity of self-reported alcohol use: a literature review and assessment. Br J Addict 1988; 83: 1019–1030
- Berkman L, Kawachi I. Social epidemiology. Oxford University Press, Oxford 2000
- Abrams J, Vela B S, Coultas D B, Samaan S A, Malhotra D, Roche R J. Coronary risk factors and their modification: lipids, smoking, hypertension, estrogen and the elderly. Curr Prob Cardiol 1995; 20: 533–610
- Law M R, Morris J K, Wald N J. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ 1997; 315: 973–980
- Law M R, Wald N J. Environmental tobacco smoke and ischemic heart disease. Prog Cardiovasc Dis 2003; 46: 31–38
- Gmel G, Rehm J, Frick U. Methodological approaches to conducting pooled cross-sectional time series analysis: the example of the association between all-cause mortality and per capita alcohol consumption for men in 15 European states. Eur Addict Res 2001; 7: 128–137
- Murray C JL, Salomon J A, Mathers C, Lopez A D. Summary measures of population health. Concepts, ethics, measurement and applications. World Health Organisation, Geneva 2002
- Williams A. Calculating the global burden of disease: time for a strategic reappraisal?. Health Econ 1999; 8: 1–8
- Üstün T B, Rehm J, Chatterji S, et al. Multiple-informant ranking of the disabling effects of different health conditions in 14 countries. Lancet 1999; 354: 111–115
- Rothman K J, Greenland S. Modern epidemiology, 2nd edn. Lippincott-Raven Publishers, Philadelphia 1998
- Taylor B J, Rehm J T. When risk factors combine: the interaction between alcohol and smoking for aerodigestive cancer, coronary heart disease, and traffic and fire injury. Addict Behav, in press
- Lopez A D, Murray C J. The global burden of disease, 1990 – 2020. Nat Med 1998; 4: 1241–1243